Quantitative, noninvasive MRI characterization of disease progression in a mouse model of non-alcoholic steatohepatitis

Abstract Non-alcoholic steatohepatitis (NASH) is an increasing cause of chronic liver disease characterized by steatosis, inflammation, and fibrosis which can lead to cirrhosis, hepatocellular carcinoma, and mortality. Quantitative, noninvasive methods for characterizing the pathophysiology of NASH...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Philip A. Waghorn, Diego S. Ferreira, Derek J. Erstad, Nicholas J. Rotile, Ricard Masia, Chloe M. Jones, Chuantao Tu, Mozhdeh Sojoodi, Yin-ching I. Chen, Franklin Schlerman, Jeremy Wellen, Robert V. P. Martinez, Kenneth K. Tanabe, Bryan C. Fuchs, Peter Caravan
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/327b39d031bd46df9de3f4c4aba0cf0e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:327b39d031bd46df9de3f4c4aba0cf0e
record_format dspace
spelling oai:doaj.org-article:327b39d031bd46df9de3f4c4aba0cf0e2021-12-02T16:31:11ZQuantitative, noninvasive MRI characterization of disease progression in a mouse model of non-alcoholic steatohepatitis10.1038/s41598-021-85679-42045-2322https://doaj.org/article/327b39d031bd46df9de3f4c4aba0cf0e2021-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-85679-4https://doaj.org/toc/2045-2322Abstract Non-alcoholic steatohepatitis (NASH) is an increasing cause of chronic liver disease characterized by steatosis, inflammation, and fibrosis which can lead to cirrhosis, hepatocellular carcinoma, and mortality. Quantitative, noninvasive methods for characterizing the pathophysiology of NASH at both the preclinical and clinical level are sorely needed. We report here a multiparametric magnetic resonance imaging (MRI) protocol with the fibrogenesis probe Gd-Hyd to characterize fibrotic disease activity and steatosis in a common mouse model of NASH. Mice were fed a choline-deficient, L-amino acid-defined, high-fat diet (CDAHFD) to induce NASH with advanced fibrosis. Mice fed normal chow and CDAHFD underwent MRI after 2, 6, 10 and 14 weeks to measure liver T1, T2*, fat fraction, and dynamic T1-weighted Gd-Hyd enhanced imaging of the liver. Steatosis, inflammation, and fibrosis were then quantified by histology. NASH and fibrosis developed quickly in CDAHFD fed mice with strong correlation between morphometric steatosis quantification and liver fat estimated by MRI (r = 0.90). Sirius red histology and collagen quantification confirmed increasing fibrosis over time (r = 0.82). Though baseline T1 and T2* measurements did not correlate with fibrosis, Gd-Hyd signal enhancement provided a measure of the extent of active fibrotic disease progression and correlated strongly with lysyl oxidase expression. Gd-Hyd MRI accurately detects fibrogenesis in a mouse model of NASH with advanced fibrosis and can be combined with other MR measures, like fat imaging, to more accurately assess disease burden.Philip A. WaghornDiego S. FerreiraDerek J. ErstadNicholas J. RotileRicard MasiaChloe M. JonesChuantao TuMozhdeh SojoodiYin-ching I. ChenFranklin SchlermanJeremy WellenRobert V. P. MartinezKenneth K. TanabeBryan C. FuchsPeter CaravanNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Philip A. Waghorn
Diego S. Ferreira
Derek J. Erstad
Nicholas J. Rotile
Ricard Masia
Chloe M. Jones
Chuantao Tu
Mozhdeh Sojoodi
Yin-ching I. Chen
Franklin Schlerman
Jeremy Wellen
Robert V. P. Martinez
Kenneth K. Tanabe
Bryan C. Fuchs
Peter Caravan
Quantitative, noninvasive MRI characterization of disease progression in a mouse model of non-alcoholic steatohepatitis
description Abstract Non-alcoholic steatohepatitis (NASH) is an increasing cause of chronic liver disease characterized by steatosis, inflammation, and fibrosis which can lead to cirrhosis, hepatocellular carcinoma, and mortality. Quantitative, noninvasive methods for characterizing the pathophysiology of NASH at both the preclinical and clinical level are sorely needed. We report here a multiparametric magnetic resonance imaging (MRI) protocol with the fibrogenesis probe Gd-Hyd to characterize fibrotic disease activity and steatosis in a common mouse model of NASH. Mice were fed a choline-deficient, L-amino acid-defined, high-fat diet (CDAHFD) to induce NASH with advanced fibrosis. Mice fed normal chow and CDAHFD underwent MRI after 2, 6, 10 and 14 weeks to measure liver T1, T2*, fat fraction, and dynamic T1-weighted Gd-Hyd enhanced imaging of the liver. Steatosis, inflammation, and fibrosis were then quantified by histology. NASH and fibrosis developed quickly in CDAHFD fed mice with strong correlation between morphometric steatosis quantification and liver fat estimated by MRI (r = 0.90). Sirius red histology and collagen quantification confirmed increasing fibrosis over time (r = 0.82). Though baseline T1 and T2* measurements did not correlate with fibrosis, Gd-Hyd signal enhancement provided a measure of the extent of active fibrotic disease progression and correlated strongly with lysyl oxidase expression. Gd-Hyd MRI accurately detects fibrogenesis in a mouse model of NASH with advanced fibrosis and can be combined with other MR measures, like fat imaging, to more accurately assess disease burden.
format article
author Philip A. Waghorn
Diego S. Ferreira
Derek J. Erstad
Nicholas J. Rotile
Ricard Masia
Chloe M. Jones
Chuantao Tu
Mozhdeh Sojoodi
Yin-ching I. Chen
Franklin Schlerman
Jeremy Wellen
Robert V. P. Martinez
Kenneth K. Tanabe
Bryan C. Fuchs
Peter Caravan
author_facet Philip A. Waghorn
Diego S. Ferreira
Derek J. Erstad
Nicholas J. Rotile
Ricard Masia
Chloe M. Jones
Chuantao Tu
Mozhdeh Sojoodi
Yin-ching I. Chen
Franklin Schlerman
Jeremy Wellen
Robert V. P. Martinez
Kenneth K. Tanabe
Bryan C. Fuchs
Peter Caravan
author_sort Philip A. Waghorn
title Quantitative, noninvasive MRI characterization of disease progression in a mouse model of non-alcoholic steatohepatitis
title_short Quantitative, noninvasive MRI characterization of disease progression in a mouse model of non-alcoholic steatohepatitis
title_full Quantitative, noninvasive MRI characterization of disease progression in a mouse model of non-alcoholic steatohepatitis
title_fullStr Quantitative, noninvasive MRI characterization of disease progression in a mouse model of non-alcoholic steatohepatitis
title_full_unstemmed Quantitative, noninvasive MRI characterization of disease progression in a mouse model of non-alcoholic steatohepatitis
title_sort quantitative, noninvasive mri characterization of disease progression in a mouse model of non-alcoholic steatohepatitis
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/327b39d031bd46df9de3f4c4aba0cf0e
work_keys_str_mv AT philipawaghorn quantitativenoninvasivemricharacterizationofdiseaseprogressioninamousemodelofnonalcoholicsteatohepatitis
AT diegosferreira quantitativenoninvasivemricharacterizationofdiseaseprogressioninamousemodelofnonalcoholicsteatohepatitis
AT derekjerstad quantitativenoninvasivemricharacterizationofdiseaseprogressioninamousemodelofnonalcoholicsteatohepatitis
AT nicholasjrotile quantitativenoninvasivemricharacterizationofdiseaseprogressioninamousemodelofnonalcoholicsteatohepatitis
AT ricardmasia quantitativenoninvasivemricharacterizationofdiseaseprogressioninamousemodelofnonalcoholicsteatohepatitis
AT chloemjones quantitativenoninvasivemricharacterizationofdiseaseprogressioninamousemodelofnonalcoholicsteatohepatitis
AT chuantaotu quantitativenoninvasivemricharacterizationofdiseaseprogressioninamousemodelofnonalcoholicsteatohepatitis
AT mozhdehsojoodi quantitativenoninvasivemricharacterizationofdiseaseprogressioninamousemodelofnonalcoholicsteatohepatitis
AT yinchingichen quantitativenoninvasivemricharacterizationofdiseaseprogressioninamousemodelofnonalcoholicsteatohepatitis
AT franklinschlerman quantitativenoninvasivemricharacterizationofdiseaseprogressioninamousemodelofnonalcoholicsteatohepatitis
AT jeremywellen quantitativenoninvasivemricharacterizationofdiseaseprogressioninamousemodelofnonalcoholicsteatohepatitis
AT robertvpmartinez quantitativenoninvasivemricharacterizationofdiseaseprogressioninamousemodelofnonalcoholicsteatohepatitis
AT kennethktanabe quantitativenoninvasivemricharacterizationofdiseaseprogressioninamousemodelofnonalcoholicsteatohepatitis
AT bryancfuchs quantitativenoninvasivemricharacterizationofdiseaseprogressioninamousemodelofnonalcoholicsteatohepatitis
AT petercaravan quantitativenoninvasivemricharacterizationofdiseaseprogressioninamousemodelofnonalcoholicsteatohepatitis
_version_ 1718383862111797248